These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 2714729)
1. Single-dose pharmacokinetics of amineptine and of its main metabolite in healthy young adults. Lachatre G; Piva C; Riche C; Dumont D; Defrance R; Mocaer E; Nicot G Fundam Clin Pharmacol; 1989; 3(1):19-26. PubMed ID: 2714729 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of amineptine after single-dose, repeated treatment and study of the at-risk populations. Riché C; Lachatre G; Guedes Y; Mocaër E; Nicot G Clin Neuropharmacol; 1989; 12 Suppl 2():S32-40. PubMed ID: 2698269 [TBL] [Abstract][Full Text] [Related]
3. Gas chromatographic-mass spectrometric assessment of the pharmacokinetics of amineptine and its main metabolite in volunteers with liver impairment. Tsaconas C; Padieu P; d'Athis P; Mocaer E; Bromet N J Chromatogr; 1989 Feb; 487(2):313-29. PubMed ID: 2722999 [TBL] [Abstract][Full Text] [Related]
4. Determination of amineptine and its main metabolite in plasma by high-performance liquid chromatography after solid-phase extraction. Rop PP; Spinazzola J; Bresson M; Conquy T; Viala A J Chromatogr; 1990 Nov; 532(2):351-61. PubMed ID: 2084131 [TBL] [Abstract][Full Text] [Related]
5. A multicenter Italian study of amineptine (Survector 100). Kemali D Clin Neuropharmacol; 1989; 12 Suppl 2():S41-50. PubMed ID: 2698270 [TBL] [Abstract][Full Text] [Related]
6. Metabolic activation of the tricyclic antidepressant amineptine--II. Protective role of glutathione against in vitro and in vivo covalent binding. Geneve J; Degott C; Letteron P; Tinel M; Descatoire V; Larrey D; Amouyal G; Pessayre D Biochem Pharmacol; 1987 Feb; 36(3):331-7. PubMed ID: 3814175 [TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer. Bonate PL; Cunningham CC; Gaynon P; Jeha S; Kadota R; Lam GN; Razzouk B; Rytting M; Steinherz P; Weitman S Cancer Chemother Pharmacol; 2011 Apr; 67(4):875-90. PubMed ID: 20582417 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males. Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571 [TBL] [Abstract][Full Text] [Related]
9. High-performance liquid chromatographic method for the determination of amineptine and its main metabolite in human plasma. Nicot G; Lachatre G; Gonnet C; Valette JP; Merle L; Nouaille Y; Bromet N J Chromatogr; 1984 Mar; 306():279-90. PubMed ID: 6715466 [TBL] [Abstract][Full Text] [Related]
10. Metabolic activation of the tricyclic antidepressant amineptine--I. Cytochrome P-450-mediated in vitro covalent binding. Geneve J; Larrey D; Letteron P; Descatoire V; Tinel M; Amouyal G; Pessayre D Biochem Pharmacol; 1987 Feb; 36(3):323-9. PubMed ID: 3814174 [TBL] [Abstract][Full Text] [Related]
11. Genetic predisposition to drug hepatotoxicity: role in hepatitis caused by amineptine, a tricyclic antidepressant. Larrey D; Berson A; Habersetzer F; Tinel M; Castot A; Babany G; Lettéron P; Freneaux E; Loeper J; Dansette P Hepatology; 1989 Aug; 10(2):168-73. PubMed ID: 2744728 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of triflusal and its main metabolite HTB in healthy subjects following a single oral dose. Ramis J; Mis R; Forn J; Torrent J; Gorina E; Jané F Eur J Drug Metab Pharmacokinet; 1991; 16(4):269-73. PubMed ID: 1823870 [TBL] [Abstract][Full Text] [Related]
14. A double-blind comparative study: amineptine (Survector 100) versus imipramine. Mendis N; Hanwella DR; Weerasinghe C; Illesinghe DS; De Silva D Clin Neuropharmacol; 1989; 12 Suppl 2():S58-65. PubMed ID: 2698272 [TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics of the antidepressant tianeptine and its main metabolite in healthy humans--influence of alcohol co-administration. Salvadori C; Ward C; Defrance R; Hopkins R Fundam Clin Pharmacol; 1990; 4(1):115-25. PubMed ID: 2341111 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and tissue residues of hydrochloric acid albendazole sulfoxide and its metabolites in crucian carp (Carassius auratus) after oral administration. Li Z; Chen C; Ai D; Wang C; Li J; Qi Y; Yi W; Shen H; Cao J Environ Toxicol Pharmacol; 2012 Mar; 33(2):197-204. PubMed ID: 22227164 [TBL] [Abstract][Full Text] [Related]
17. The beneficial effects of amineptine (Survector 100) in the treatment of depression: preliminary results of an Indian multicenter trial. Boral GC; Shah LP Clin Neuropharmacol; 1989; 12 Suppl 2():S51-7. PubMed ID: 2698271 [TBL] [Abstract][Full Text] [Related]
18. Phase I pharmacokinetics study of high-dose fotemustine and its metabolite 2-chloroethanol in patients with high-grade gliomas. Tranchand B; Lucas C; Biron P; Giroux B; Gordon B; Richards R; Solere P; Roux N; Evene E; Mornex F Cancer Chemother Pharmacol; 1993; 32(1):46-52. PubMed ID: 8462123 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of high-dose oral CCNU in bone marrow transplant patients. Kastrissios H; Chao NJ; Blaschke TF Cancer Chemother Pharmacol; 1996; 38(5):425-30. PubMed ID: 8765435 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic study of fentiazac and its main metabolite hydroxyfentiazac in the elderly. Houin G; Lapeyre C; Rochas MA; Tufenkji AE; Campistron G; Coulais Y; Akbaraly JP; Grislain L; Beck H Arzneimittelforschung; 1993 Jan; 43(1):50-3. PubMed ID: 8447848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]